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Summary 
We  have  recently  identified  a  dominant  wave  of  CD4-CD8-  (double-negative  [DN]) 
thymocytes in early murine fetal development that express low affinity Fc  3, receptors (FcyRII/III) 
and contain precursors for Tic~/3 lineage T  cells. Here we show that Fc'yRII/III is expressed 
in very immature CD4 l~  single-positive (SP)  thymocytes and that  Fc3,RII/III expression is 
downregulated within the DN subpopulation and before the CD3-CD8 l~  SP stage in T  call 
receptor (TCR)-a/3 lineage-committed thymocytes. DN Fc"t'RII/III + thymocytes also contain 
a small fraction of TCR-3'/t5 lineage cells in addition to TCR-c~/3 progenitors. Fetal day 15.5 
DN  TCR-a/B  lineage progenitors  can  be  subdivided  into  three  major  subpopulations  as 
characterized by cell surface expression of Fc'yRII/III vs. CD2 (Fc'yRII/III+CD2 - , Fc3'RII/ 
III +  CD2 +, Fc3,RII/III- CD2 +). Phenotypic analysis during fetal development as well as adop- 
tive transfer of isolated fetal thymocyte subpopulations derived from C57B1/6 (Ly5.1) mice into 
normal, nonirradiated Ly5.2 congenic recipient mice identifies one early differentiation sequence 
(FcyRII/III +  CD2-  "-* Fc'yRII/III +  CD2 + "-~ Fc3,RII/III-  CD2 +) that precedes the entry of 
DN thymocytes into the CD4+CD8 + double-positive (DP) TCR  l~  stage.  Unseparated day 
15.5 fetal thymocytes develop into DP thymocytes within 2.5  d  and remain at the DP stage 
for >48 h before being selected into either CD4 + or CD8 + SP thymocytes. In contrast, Fc~/RII/ 
III+CD2 -  DN thymocytes follow this same developmental pathway but are delayed by "~24 h 
before entering the DP compartment, while Fc'yRII/III-CD2 § display accelerated development 
by *24 h compared with total day 15.5 thymocytes. Fc'yRII/III-CD2 + are also more develop- 
mentally advanced than Fc3,RII/III+CD2 -  fetal thymocytes with respect to their TCR ~/chain 
V(D)J rearrangement. At day 15.5 in gestation, ~ chain V(D)J rearrangement is mostly, if not 
entirely, restricted to the Fc3,RII/III-CD2 + subset of DN fetal thymocytes. Consistent with 
this analysis in fetal thymocytes, >90% of aduh thymocytes derived from mice carrying a disrupting 
mutation at the recombination-activating gene 2 locus (RAG-2-/-) on both alleles are develop- 
mentally arrested at the DN CD2-  stage.  In addition, there is a fivefold increase in the relative 
percentage of thymocytes expressing Fc3,RII/III in TCR and immunoglobulin gene rearrangement- 
incompetent homozygous RAG-2-/-  mice (15% Fc3,RII/III §  versus rearrangement-competent 
heterozygous RAG-2 +/-  mice (<3%  FcyRII/III+).  Thus,  Fc3'RII/III  expression defines an 
early DN  stage preceding Vo(D~)Ja  rearrangement, which in turn is followed by surface ex- 
pression of CD2. Loss of Fc3,RII/III and acquisition of CD2 expression characterize a late DN 
stage immediately before the conversion into DP thymocytes. 
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adult bone marrow-derived progenitor cells that colo- 
nize the fetal thymus continuously beginning around day 12 
in the development of the mouse (1, 2). Progenitor activity 
giving rise to both T  cell (Tiot//~ and Ti3'//$)  lineages has 
been identified in the CD4-CDS-  double-negative (DN) 1 
population of thymocytes (reviewed in references 3-6). DN 
thymocytes represent the major population in the early fetal 
thymus ('~95%  at day 15.5 in gestation of the mouse) and 
are reduced to ~5% in the adult thymus due to the presence 
of more developed thymocytes. TCK-od~ lineage thymocytes 
begin to rearrange their TCK genes at the DN stage (7-9) 
and pass  through a  CD3-CD8 I~  (10,  11)  stage into  the 
CD4 +  CD8 + double-positive (DP) TCR  l~  stage. On the 
basis  of their TCK specificity,  DP thymocytes are selected 
into  CD4 + or CDS+TCR.hig a single-positive (SP)  mature 
thymocytes that  populate the peripheral lymphoid organs 
(reviewed in reference 12). 
We have recently identified a wave of DN thymocytes in 
early fetal development (day 14.5 in gestation) that express 
Fc receptors for IgG (FcyKII/III) (13). Intrathymic transfer 
of purified fetal DN Fc'yKII/III + thymocytes demonstrated 
the Tio~/~ lineage progenitor activity of these cells. Develop- 
mental progression included the conversion from the CD3- 
CD4-CD8-FcTKII/III §  stage to the CD3+CD4+CD8+ 
stage and the subsequent selection into CD4 or CD8 SP ma- 
ture T  cells. Of note, FcyKII/III expression was shown to 
be downregulated between the DN and DP stages.  How- 
ever, CD3 - CD4- CD8- Fc~RII/III § thymocytes also con- 
tained precursor activity for the generation of NK cells. This 
property became apparent upon removal of fetal thymocytes 
from the thymus and subsequent in vitro culture in the pres- 
ence of IL-2 or upon intravenous transfer into recipient mice. 
In contrast to the loss of FcTKII/III expression during intra- 
thymic development, FcTRII/III expression was maintained on 
cellular progeny derived from CD3- CD4- CD8 - Fc'yRII/ 
III + cells outside the thymus (13). 
While the percentage of FcyKII/III-expressing thymocytes 
declines during early fetal development, the number of CD2- 
expressing thymocytes increases (14, 15). The early onset of 
CD2 expression (day 14 in gestation) in developing thymo- 
cytes led to  the speculation that  CD2-mediated adhesion 
and/or signaling might play a role in thymus-specific differen- 
tiation (16). Furthermore, the loss of Fc'yKII/III expression 
and the acquisition of CD2 expression during early T  cell 
ontogeny suggest that there are additional developmentally 
and phenotypically distinct subpopulations of DN thymo- 
cytes just before the transition into the DP stage.  Here we 
report on the identification of such distinct subsets  of DN 
thymocytes as defined by their expression of Fc'yKII/III and 
CD2, their TCR/3 chain rearrangement status, and their in 
vivo differentiation kinetics in normal recipient mice. The 
elucidation of this developmental sequence within DN thymo- 
cytes is entirely consistent with the differentiation block that 
1 Abbreviations used in this paper: DN, double  negative;  DE double  positive; 
HSA, heat-stable  antigen; KAG-2, recombination-activating  gene 2; SP, 
single positive. 
occurs in  TCR  gene rearrangement-incompetent animals 
whose RAG-2 genes (17,  18) have been disrupted on both 
alleles (19).  Moreover, analysis of CD3-CD4-CD8-  thy- 
mocytes from adult mice identified the same phenotypic stages 
as found among fetal thymocytes, suggesting that these sub- 
populations of DN thymocytes are part of a functional de- 
velopmental pathway in the adult thymus as well. Finally, 
while the majority of the DN FcyRII/III + subset are ap- 
parently  TCR-ol//~  progenitors,  a  small  fraction  of DN 
FcyRII/III + thymocytes enter the TCR-y/8 lineage. 
Materials and Methods 
Mice.  C57B1/6 (Ly5.1) mice were obtained from The Jackson 
Laboratory (Bar Harbor, ME) and breeding stocks of the congenic 
strain B6Ly5.2 (Ly5.2) were kindly provided  by Dr. Clarence Reeder 
(National Cancer Institute, Frederick, MD) and maintained at the 
Redstone  Animal Facility at  the Dana-Farber Cancer Institute 
(Boston, MA). Thymocytes were isolated from fetal mice that were 
obtained from timed pregnant C57B1/6 mice. The day of the vag- 
inal plug  was counted  as day 1 of pregnancy. RAG-2 -/-  and 
RAG-2 +/- mice (19) were kept under specific pathogen-flee con- 
ditions. 
mAbs.  The following primary antibodies were used in this 
study: biotinylated  2.4G2, FITC-conjugated  2.4G2 (20), PE-coupled 
53-2.1 (21) (anti-Thy-1; Gibco BRL, Gaithersburg, MD), FITC- 
conjugated M1/69  (22) (anti-HSA; Pharmingen,  San Francisco, 
CA), biotinylated 7D4 (23) (antiqL-2R [p55]), biotinylated RM2-1 
(24) (anti-CD2; Pharmingen), control antibody Y13-238 (25) (anti- 
p21 ras), PE-coupled  YCD3-1 (26) (anti-CD3; Gibco BRL), FITC- 
labeled 145-2Cll  (anti-CD3) (27), FITC-labeled 3A10 (anti-pan 
Ti'y/~) (28) PE-coupled GK1.5 (29) (anti-CD4; Becton Dickinson 
& Co., Mountain View, CA), biotinylated 53-6.7 (21) (anti-CD8; 
Becton Dickinson & Co.), Ked613-coupled  53-6.7 (anti-CD8; Gibco 
BRL), PE-coupled RA3-6B2 (30) (anti-B220; Caltag, San Fran- 
cisco, CA), aUele-specific  FITC-conjugated 104-2.1 (anti-Ly5.1)  (31), 
FITC-labeled A20-1.7 (anti-LyS.2) (31). Both  hybridomas were 
kindly provided by Dr. S. Kimura (Sloan-Kettering  Cancer Center, 
New  York). Second-step reagents  were  streptavidin-PE  and 
streptavidin-FITC (Tago Inc., Burlingame, CA). mAbs were grown 
as culture supernatants and depending on the species and isotype 
purified on protein A- or protein G-Sepharose (Pharmacia LKB, 
Uppsala, Sweden). mAbs were biotinylated using NHS-LC-Biotin 
(Pierce Chemical Co., Rockford, IL) following the manufacturer's 
recommendations and FITC labeled using fluorescein-5-isothio- 
cyanate (FITC Isomer I; Molecular Probes, Eugene, OR) using 
standard procedures  (32). Following the labeling procedures,  specific 
reactivity of mAbs was analyzed by FACS  |  (Becton Dickinson & 
Co.) and the optimal antibody dilutions were subsequently used. 
Immunofluorescence Staining Analysis, and Cell Sorting.  For pheno- 
typic analysis, thymocytes were obtained from normal fetal mice 
at different days of timed pregnancies, or at the indicated times 
after cell transfer into recipient mice, and stained with mAbs as 
indicated in the figure legends. 0.5-1  x  106 cells from single-cell 
suspensions were incubated with purified mAbs at 5-10/~g/ml in 
PBS, 5% FCS for 15-30 min on ice, washed in PBS, 5% FCS and, 
if necessary, incubated with the appropriate second-step reagents 
for 15-30 min on ice. Flow cytofluorometric  analysis  was performed 
on a FACScan  |  (Becton Dickinson & Co.). In experiments shown 
in Figs. 1-3, 6, and 7, 104 cells were analyzed. For reanalysis of 
donor-type cells (summarized in Fig. 4 B), 5  x  104 cells were ana- 
lyzed, in each case gating on viable cells by forward angle and side- 
ward scattering properties. Fluorescence data are displayed  as loga- 
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software (Becton Dickinson & Co.). 
For cell sorting, fetal thymocytes derived from timed pregnant 
C57B1/6 mice (day 15.5) were stained with 2.4G2-FITC (10/zg/ml) 
and CD2-biotin (1:50 dilution) followed by avidin-PE  (1:50 dilu- 
tion) and separated into CD2 § Fc3,RII/III- and CD2- Fcq,  RII/ 
III + subpopulations at a flow rate of 1,500 cells/s using an EPICS 
750 series cell sorter (Coulter Electronics, Hialeah, FL). Sorted cell 
populations were reanalyzed for their purity and were found to 
be at least 97% pure. For control purposes, fetal day 15.5 thymo- 
cyte (FT day 15.5) total cells were stained with 2.4G2-FITC (10 
#g/ml) and CD2-biotin (1:50 dilution), followed by avidin-PE, but 
not separated  before intrathymic injection. 
Enrichment  of  Ly5.1 +  Cells through Magnetic Bead  Separa- 
tion.  For enrichment of LyS.1 § cells from Ly5.2 recipient mice, 
thymocytes were incubated with purified A20-1.7  (anti-LyS.2)  at 
10 #g/ml for 30 rain on ice and washed in PBS, 5% FCS. Mag- 
netic goat anti-mouse IgG beads (Advanced Magnetics, Cambridge, 
MA) were washed twice by placing the magnetic bead suspension 
between two strong magnets, removing liquid, and resuspending 
beads in PBS, 5% FCS. Thymocytes were then incubated with mag- 
netic beads (1 ml magnetic bead suspension/107  cells) for 30 min 
on ice. To remove LyS.2 § cells bound to magnetic beads, the sus- 
pension was placed between two magnets until fluid was clear (,o5 
min). Fluid, enriched in Ly5.1 + cells, was then removed and again 
incubated with an equivalent amount of magnetic beads for 30 min 
on ice. For the final separation, the suspension was placed between 
magnets and the transparent fluid removed. This last step was re- 
peated three times to obtain maximum enrichment of LyS.1 § cells. 
This procedure yielded 5-50-fold enrichment of donor-type cells 
relative to  host  cells. In  general,  50-500  (0.1-1%) donor-type 
cells were observed per 5  x  104 total thymocytes analyzed with 
no significant difference detected when comparing the cell numbers 
of progeny  of the  injected  DN  FcyRII/III+CD2 -  and  DN 
FcyRII/III-CD2 + subpopulations. 
Isolation of Adult  CD3-CD4-CD8-  Thymocytes.  To prepare 
adult CD3-CD4-CDS-  thymocytes, normal adult  thymocytes 
were incubated  at a concentration of 2  x  10Vml with PE-coupled 
GK1.5 (10 #g/ml) and biotinylated 53-6.7 (10 #g/ml) for 30 min 
on ice. After extensive washing the cells were resuspended at a con- 
centration of 107/ml with magnetic goat anti-rat IgG beads (Ad- 
vanced Magnetics) at a ratio of 10-50 particles/cell  and incubated 
for 30 min on ice. CD4 + and CD8 + thymocytes binding to mag- 
netic beads were subtracted using two magnets (Advanced Mag- 
netics) as described above. The latter step was repeated twice. By 
this time, CD4-  and CD8- thymocytes were enriched to "o60%. 
To further purify the DN population and to remove DN CD3 + 
cells, the remaining cell population was restained with PE-coupled 
GK1.5 (10 #g/ml), biotinylated 53-6.7 (10 #g/ml), and PE-coupled 
YCD3-1 for 30 min on ice, washed, and subsequently incubated 
with streptavidin-PE. PE-negative thymocytes (corresponding to 
CD3-CD4-CDS-  thymocytes) were sorted on an EPICS 750 se- 
ries cell sorter (Coulter Electronics).  Postsorter analysis showed the 
purity of the sorted population to be >97%. 
Intrathymic Injections.  Intrathymic injections were performed as 
described (13, 33, 34). Briefly, 4-6-wk-old mice were anesthetized 
with Avertin (2.5% solution, 10/A per gram body weight) as de- 
scribed (35) and injected intrathymically without prior irradiation. 
For injections, mice were positioned on their back, a small incision 
(<5 mm) was made in the skin above the sternum without opening 
the thorax, and cells were injected into each thymic lobe by posi- 
tioning the needle for injection from cranio-lateral to caudo-medial 
and injecting through  the thorax wall above the clavicle. Cells 
(10S/thymus)  were injected using a 1-ml syringe (Insulin Syringe; 
Becton Dickinson & Co., Rutherford, NJ) placed into a stepper 
(Tridak,  Brookfield, CT) in 20 #1 PBS with 5%  FCS per lobe. 
Subsequently, the skin wound was closed using surgical metal clips. 
Template Preparation for PCR Analysis.  Genomic DNA from 
various  tissues  was isolated  from C57B1/6 mice.  Single-cell sus- 
pensions from fetal liver, fetal thymus, and adult lymph nodes were 
washed in cold PBS, resuspended in cold PBS, 0.5% NP-40, and 
incubated on ice for 15 min. Nuclei were spun down, resuspended 
in 0.5 ml TNE (50 mM Tris, 100 mM NaC1, 1 mM EDTA) with 
0.5 mg/ml proteinase K and 1% SDS, and incubated overnight 
at 37~  Genomic DNA was extracted once with TE-saturated 
phenol and once with chloroform and precipitated with 0.3 M 
NaOAc (pH 5.9) and ethanol. 
PCR and Southern Hybridization Analysis.  PCR was carried out 
as described (36). In brief, we used "o100 ng (or dilutions thereof) 
of DNA template, 5 pmol of primers Jf12.5 (5'-TAACACGAC- 
GAGCCGAGTGC-3') and Vfl6 (5'-GAAGGCTATGATGCGTC- 
TCG-Y), 10 pmol of primer Vfl8 (5'-TCCCTGATGGGTACAA- 
GGCC-Y),  and  1  U  of taq  polymerase (Perkin  Elmer  Cetus, 
Norwalk, CT) in 50 #1 final volume. The samples were denatured 
(94~  1 min), annealed (64~  1 min) and extended (72~  30 s) 
for 35 cycles. Aliquots from each sample were size fractionated on 
a 1.5% Tris-borate-EDTA  agarose gel, denatured in 0.25 M HC1, 
and blotted onto a zeta probe membrane (Bio-Rad Laboratories, 
Richmond, CA) in 0.4 M NaOH. Blots were then hybridized with 
a Jfl2.5-specific oligonucleotide probe (5'-CTGGCCCAAAGTACT 
GGGTG-Y) using standard methods (36). 
To control the integrity and amount of genomic DNA tem- 
plates, a genomic sequence within exon 8 of CD3~" was amplified 
using the sense oligonucleotide (5'-CAGACCCTGGCC CCTCGC- 
3')  and the antisense  oligonucleotide (5'-GCTACCCCAGGCT- 
CACCAC-Y).  The samples were denatured (94~  1 min), an- 
nealed (62~  1 rain), and extended (72~  1.5 rain) for 35 cycles. 
Blots were hybridized with a CD3~" exon 8-specific oligonucleo- 
tide probe (5'-GGGCTTCACCTGCTGATGTC-3'). All oligonu- 
cleotides were made on a synthesizer (381A; Applied Biosystems, 
Inc., Foster City, CA) using standard fl-cyanoethylphosphoramidate 
chemistry. 
Statistical Analysis.  To determine the statistical  significance of 
kinetic differences in the development of various fetal thymocyte 
populations 1.5-7.5 d postintrathymic injection as measured in the 
experiments summarized in Fig. 4 B, a permutation test (37) was 
used to determine the difference between the control population 
(FT day 15.5  total)  and either Fc3,RII/III+CD2 -  or Fcq,  RII/ 
III-CD2 § . The test statistic used was the sum, over times, of the 
squares of the differences between the sample averages of the per- 
centages. The permutations were the relabelings of group identity 
that fixed the number of observations at each time and in each 
group (with p  <0.001). 
Results 
Expression  of Fo,  RII/III  on Fetal Thyrnocytes  Is Restricted 
to Immature CD41~  -  and DN Stages.  To examine the 
expression of FcvRII/III  on subpopulations  of developing 
thymocytes, FT day 17.5 were analyzed for surface expres- 
sion of CD4, CD8, and Fcq'RII/III by three-color immuno- 
fluorescence (Fig. 1, A  and B). FT day 17.5 was chosen for 
this analysis because this developmental stage displays three 
distinct  immature thymocyte populations  expressing CD4 
and  CD8  differentially:  DN,  CD3-  CD8 l~  SP,  and  DP 
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Figure  1.  FcTRII/III  expression  on  CD4-CD8-  (DN)  and 
CD41owCD8-  thymocytes during early fetal development.  Fetal thymo- 
cytes derived from timed pregnant CD57B1/6  mice at day 17.5 (,4 and 
B) or day 15.5 (C and D) of gestation were analyzed by three-color flow 
cytometry for the expression of CD4, CD8, and Fc~RII/III. Overlay histo- 
grams (B and D) display FcTRII/III expression of gated thymocytes popu- 
lations  (A  and  C).  Fc"/RII/IlI  expression  on  CD4-CD8-  (DN), 
CD4-CD8 ~~  (CDS~~  and CD4+CD8 +  (DP)  subpopulations is 
shown in B, and on the CD4~~  subset in D, Overlay histograms 
represent specific  staining of a gated subpopulation with FITC-labeled 2.4G2 
(anti-FcTRII/lII) (bold lines) vs. staining of the same subpopulation with 
FITC-labeled 2.4G2 after preincubation with excess of unlabeled 2.4G2 
(thin  lines). 
subsets. Gated subpopulations of DN, CD8  l~  SP, and DP 
(Fig.  1 A)  were  analyzed  for  their  expression  levels of 
FcTRII/III. This analysis revealed the highest expression of 
FcTKII/III on the DN population, while both immature 
CD8  l~  SP and DP thymocytes are FcTRII/III- (Fig. 1 B). 
Overlay histograms shown in Fig. 1 B compare specific  staining 
of thymic subpopulations with FITC-labeled mAb 2.4G2 (bold 
lines) vs. 2.4G2-FITC staining of the same subpopulations 
after preincubation with an excess of unlabeled 2.4G2 (thin 
lines). This expression pattern is consistent with our previous 
observation of a parallel decline in the percentage of DN and 
FcTRII/III + fetal  thymocytes during gestation in situ as 
well  as  the  loss  of Fc3,RII/III on adoptively transferred 
FcTRII/III + DN T  cell progenitors during their develop- 
ment from the DN to the DP stage in the thymus (13). 
The above results indicated that FcTRII/III expression is 
found at the DN stage and lost before further differentia- 
tion.  To analyze  FcyRII/III expression  on yet earlier  in- 
trathymic progenitor cells, we examined the 2.4G2 reactivity 
on the recently described CD4  ~~  SP immature population, 
which precedes  the DN  stage  (38,  39).  Three-color im- 
munofluorescence analysis on FT day 15.5 for CD4, CDS, 
and FcTRII/III (Fig. 1 C) revealed that FcTRII/III was also 
expressed on the majority of the CD4  l~  SP immature popu- 
lation (Fig. 1 D). This finding indicates that a very early in- 
trathymic T cell progenitor population expresses Fc3,KII/III. 
Several Distinct Subpopulations of DN Fetal Thymocytes Are 
Defined during Early Development by FcyRII/III Expression. 
DN thymocytes can be subdivided into phenotypic subpopu- 
lations by expression of a number ofceU surface proteins (40, 
41), i.e., the IL-2R eL chain (p55) (34, 42),  the levels of ex- 
pression of Thy-1 (43), heat-stable antigen (HSA) (44, 45), 
and CD2 (14, 15). To analyze the presence or absence of these 
early  stage-related markers on FcTKII/III §  and FcTKII/ 
III- thymocyte populations, thymocytes derived from days 
14.5, 15.5, and 16.5 of fetal development, respectively, were 
stained for expression of Fc'yKII/III vs. Thy-1  (Fig.  2 A), 
IL-2R (p55) (Fig. 2 B), CD2 (Fig. 2 C), and HSA (Fig. 2 
D).  This  analysis reveals heterogeneity among  FcTRII/ 
III + and FcTKII/III-  thymocytes. While the majority of 
FcTKII/III +  thymocytes  at  day  14.5 are  Thy-lhig  h  and 
HSAhig  h (Fig. 2, A  and D, top), a minority of Fc3,RII/III + 
thymocytes express medium to low levels of Thy-1 and HSA. 
As  has  been  described  previously,  the  number  of 
FcyRII/III + thymocytes drastically declines during fetal de- 
velopment (13). However, the expression levels of Thy-1 and 
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Figure  2.  Several  distinct subpopulations of fetal 
thymocytes are defined during early fetal development 
by Fc~RII/IlI expression.  Fetal thymocytes derived 
from timed pregnant C57B1/6 mice at days 14.5, 15.5, 
and 16.5 of gestation were analyzed by flow cytom- 
etry for expression of FcTKII/III vs. Thy-1 (A), IL- 
2R a  chain (p55) (B), CD2 (C), and HSA (D). Note 
the downregulation of FcTRII/III expression during 
this early stage of thymic development while the ex- 
pression levels of Thy-1 and lISA remain high (.4 and 
D). The loss of FcTRAI/III expression appears to pre- 
cede the loss of IL-2 K (p55) expression (/3). Analysis 
of cell surface expression of FcTKI[/IlI vs. CD2 (C) 
suggests an early developmental sequence involving 
the following phenotypic stages of DN thymocytes: 
FcTRII/III+CD2 -  --.  FcTRII/III+CD2 + 
FcTRlI/III - CD2 +. 
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2, A and D). In contrast, analysis of developing thymocytes 
for FeyRII/III vs. Ib2R (p55) (Fig. 2 B) reveals a major popu- 
lation of predominantly FcyRII/III + IL-2R (p55) + day 14.5 
thymocytes and a minor population of FcyRII/III + IL-2R 
(p55) ~~  day 14.5 thymocytes (Fig.  2 B,  top). The loss of 
Fc3,RII/III appears to precede the loss of IL-2R (p55) on day 
15.5 fetal cells (Fig. 2 B,  middle), before thymocytes enter 
a Fc~/RI[/III-  IL-2R (p55)-  stage on day 16.5 (Fig.  2 B, 
bottom). Analysis of cell surface expression of Fcq'RII/III vs. 
CD2  (Fig.  2  C)  demonstrates  that  the  majority  of 
Fc3,RII/III + thymocytes at day 14.5 are CD2  l~  (Fig. 2 C, 
top). As thymic development proceeds, thymocytes appear to 
first enter a Fcq,  RII/III + CD2 + stage (Fig. 2 C, middle), be- 
fore the loss of Fcq,  RII/III is accompanied by high expres- 
sion of CD2 (Fig. 2 C, bottom). These data suggest the possi- 
bility  of an  early  developmental sequence  involving the 
following phenotypic stages of DN thymocytes: Fc3'RII/ 
IlI+CD2 -  -~ Fc3,RII/III+CD2 + "-~ Fcq,  RII/III-  CD2 +. 
A  Fraction of the DN FcTRII/III + Thymocytes Is  Com- 
mitted to  the  TCR-7/8  Lineage.  Since  the  first  wave of 
TCR + thymocytes in fetal development consists of TCR- 
y/~  lineage  cells  (reviewed  in  reference  46),  the  DN 
Fcq,  RII/III + thymocyte subset was analyzed for its poten- 
tial content of TCIk-'y/?) lineage cells. Based on the observa- 
tion that the percentage of TCR-3'/~ lineage cells reaches 
its peak level (~5%  of the total thymocytes) at day 16.5 of 
gestation (28),  fetal thymocytes from this day of gestation 
were  analyzed  by  flow  cytometry  for  coexpression  of 
FcyRII/III and CD3 (Fig.  3 C) or TCR-7/~ (Fig.  3 D), 
respectively. Negative and single-color controls are shown 
in Fig.  3, A  and B. Specificity of the anti-CD3 and anti- 
TClk-3,/t~ staining was ensured by control cells that were prein- 
cubated with an excess of unlabeled mAb 2Cll (anti-CD3) 
or unlabeled mAb 3A10 (anti-pan TCR-3'/6) before staining 
with 2ClI-FITC (Fig. 3, A and B) or 3AIO-FITC (not shown). 
Confirming the dominance of TCR-3'/~ cells among early 
TCR  thymocytes  (28,  46),  this  analysis  revealed  '~5% 
CD3 § cells at day 16.5 of gestation (Fig. 3 C) that belong 
almost entirely to the TCR-y//~ lineage (Fig. 3 D). The vast 
majority of Fcq,  RII/III + thymocytes are CD3-,  which is 
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Figure 3.  A fraction ofDN FeyRII/III* thymocytes is committed to 
the TCR-~/~ lineage. FT day 16.5 were stained with AvPE vs. 2Cll-FITC 
after preincubation with excess of unlabeled 2Cll (A), with 2.4G2-biotin 
followed by AvPE vs. 2Cll-FITC after blocking with excess of unlabeled 
2Cll (B). In C and D, FT day 16.5 were stained with 2.4G2-biotin fol- 
lowed by AvPE vs. 2Cll (anti-CD3)-FITC (C) and 3A10 (anti-pan TCR- 
￿9  y/~)-FITC (D), respectively. 
consistent with the observed downregulation of Fcq,  RII/III 
at the DN stage (Fig. 1, A and B). However, a small fraction 
of DN Fc3,RII/III + thymocytes also coexpress CD3 (Fig. 
3 C) and are TCR-3,/~ lineage cells (Fig. 3 D). 1.4% of the 
total thymocytes are DN Fcq,  RII/III § TCR-3,/~ + thymo- 
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Figure 4.  Developmental kinetics in vivo of DN FcyRII/III  +CD2- 
and DN FeyRII/III-CD2* delineates early and late stages of DN subsets 
before differentiation into DP and SP thymocytes.  FT day 15.5 derived 
from timed pregnant C57B1/6  (Ly5.1) mice were stained for expression 
of Fcq,  KlI/llI and CD2, and separated according to the sorting windows 
shown  in  A  (left).  Reanalysis  of  sorted  Fc3,RII/III+CD2 -  and 
FcyRII/III-CD2 +  subpopulations is  shown  in A  (middle and  right, 
respectively). Subsequently,  each subpopulation was injected intrathymi- 
cally (10  s cells/thymus) into normal nonirradiated B6Ly5.2 congenic re- 
cipient mice. In daily intervals from 1.5 to 7.5 d and on day 10.5 after 
cell transfer in vivo, donor-type thymocytes were retrieved from recipient 
thymi and enriched relative to host thymocytes by depletion with anti-Ly-5.2 
mAb and goat anti-mouse magnetic beads followed by magnetic separa- 
tion. Subsequently,  developmental progression of donor-type thymocytes 
was analyzed by three-color immunofluorescence for Ly5.1, CD4, and CDg. 
Progeny of each subpopulation generate first a single wave ofDP (B, too), 
and subsequently mature CD4 SP (B, bottom) and CD8 SP (not shown). 
Kinetic shifts in this intrathymic development are apparent when com- 
paring total FT day 15.5 (stained for expression of FcyRlI/IIl and CD2 
but not separated) (m) with Fc3,RII/III  +  CD2- thymocytes (O) and with 
FcyRII/III-CD2*  thymocytes (A), respectively. By day 7.5 and later, 
the proportion of CD4 SP thymocytes has reached the level found in ma- 
ture donor-derived peripheral T  cells (B, bottom). 
1083  Rodewald et al. cytes  in  this  experiment.  Among the  TCR-3,/g  lineage 
cells this corresponds to ,025% FcyRII/III +. Hence, DN 
Fc'yRII/III +  thymocytes  contain  cells  of  heterogeneous 
lineages with the majority apparently being TCR-o~//3 lineage 
cell progenitors and a small fraction entering the TCR-3,/6 
lineage. 
In Vivo Developmental  Kinetics of DN FcTRII/III § CD2- 
and DN FcTRII/III-CD2 + Thymocytes Delineate Early and 
Late DN Stages before Differentiation into DP Thymocytes.  To 
test directly the developmental sequence suggested by ex vivo 
phenotyping of fetal thymocytes for expression of FeyRII/III 
and CD2, FT day 15.5 were stained for FcyRII/III and CD2 
and  subsequently  separated  into  FcyRII/III+CD2 -  and 
FcyRII/III-CD2 + subpopulations by cell sorting according 
to the sorting gates as shown in Fig. 4 A (left). Day 15.5 of 
gestation  represents  a  stage  of  development containing 
FcyRII/III +  CD2-,  Fc3,RII/III +  CD2 +,  and FcyRII/III- 
CD2 +  subpopulations (Fig.  2  C,  middle, and Fig.  4 A). 
Postsorter  analysis  showed that  the isolated Fc3,RII/III + 
CD2-  thymocytes contained x<0.5% of contaminating cells 
from the Fc3,RII/III-CD2 + subpopulation. The Fc3,RII/ 
III- CD2 + subset of DN thymocytes gated by cell sorter was 
-.<3% contaminated by Fc3'RII/III+CD2 -  thymocytes. Sub- 
sequently, the developmental stage and differentiation potential 
of these early thymocyte subpopulations were assessed. To 
this end, the in vivo development of total DN day 15.5 thymo- 
cytes was compared in parallel to putatively more immature 
Fc3,RII/III+CD2 -  and  more mature FcTRII/III-CD2 + 
subpopulations, respectively, by intrathymic injection of in- 
dividual subpopulations. 
Since preliminary experiments revealed a general develop- 
mental delay of ,04 d when FT day 15.5 were transferred 
into irradiated recipients when compared with nonirradiated 
recipients (data not shown), all subsequent experiments for 
in vivo precursor activity and kinetics were performed in nonir- 
radiated recipients. Precursor cell transfer into the nonirradi- 
ated thymic microenvironment should facilitate donor cell 
development that closely resembles the development in the 
normal thymus and allows "real-time" measurements between 
developmental steps in vivo (34). Consequently, cell sorter- 
purified thymocyte subpopulations from C57B1/6 mice (LyS.1) 
were injected intrathymically (10  s cells/thymus) into nor- 
mal, nonirradiated B6Ly5.2 congenic mice. In daily intervals 
from 1.5 to 7.5 d after cell transfer in vivo, donor-type thymo- 
cytes were retrieved from recipient thymi. Donor-type thymo- 
cytes were enriched relative to host thymocytes by depletion 
with anti-Ly5.2 mAb and goat anti-mouse magnetic beads 
followed by magnetic separation. Subsequently, developmental 
progression of donor-type thymocytes was analyzed by three- 
color immunofluorescence for Ly5.1, CD4,  and CDS. 
All three tested populations from day 15.5 in gestation (FT 
day 15.5 total, Fc3,RII/III+CD2 - , and Fcq,  RII/III-CD2 +) 
give rise to an initial single wave of DP (Fig. 4 B, top) and 
subsequently mature SP thymocytes (Fig. 4 B, bottom), indi- 
cating their T cell progenitor activity in a thymic environ- 
ment. 2.5 d after intrathymic injection of total FT day 15.5, 
,090% of donor-type cells are at the DP stage. Beginning 
at day 4.5 postinjection (duration of the DP stage >--48 h), 
the number of DP declines  as donor-type thymocytes are 
selected into CD4 SP (Fig. 4 B) and CD8 SP (not shown) 
mature cells. By day 7.5 postinjection, <10% of donor-type 
thymocytes are DP. At this time and later (day 10.5; Fig. 
4 B, bottom), cellular progeny of total day 15.5 fetal progen- 
itors have generated ,060%  CD4 SP and "~30%  CD8 SP 
(not shown) thymocytes, thus reflecting the proportions of 
CD4 + (Fig. 4 B, bottom right) to CD8 + mature donor-type 
T  cells found in the periphery. 
A  shift in the kinetics of individual subpopulations was 
detected when this in vivo differentiation analysis in normal 
mice was applied in parallel experiments to DN subpopula- 
tions characterized by selective expression of FcyRII/III and 
CD2. Both precursor cell populations give rise to a single 
wave of DP thymocytes. However, DN FcTRII/III +  CD2- 
displayed delayed developmental kinetics by ,024 h when com- 
pared with total FT day 15.5, while DN FeyRII/III-CD2 + 
showed accelerated development by ,024 h. To test the statis- 
tical significance of the observed kinetic differences, a per- 
mutation test was used to analyze the difference between the 
control population (FT day 15.5 total) and either Fc3,RII/ 
III+CD2 -  (p  <0.001)  or  Fc3,RII/III-CD2 +  (p <0.001). 
While ,070% of the cellular progeny of DN Fcq,  RII/III- 
CD2 + were at the DP stage after 1.5 d in vivo, only "015% 
of Ly5.1 donor-type cells had developed into DP thymocytes 
at this time point after injection of DN FcyRII/III +  CD2- 
(Fig. 4 B). Consequently, the first mature SP cells (CD4 SP) 
began to  appear  3.5  d  after  transfer  of DN  FcyRII/III- 
CD2 +,  in contrast to  5.5  d  for DN  FcyRII/III+CD2 -. 
Note that the decline of the percent of DP donor-type thymo- 
cytes corresponds to the transition from the DP to the SP 
stage as shown in Fig. 4 B. Collectively,  these experiments 
demonstrate that the Fe~RII/III +  CD2-  subpopulation rep- 
resents an early DN stage while FcTRII/III-CD2 + mark 
a late stage among DN fetal thymocytes. The developmental 
lag time between the two analyzed populations is "48 h. 
TCR fl'Chain V(D)J Rearrangement Status in FT Day 15.5 
Subpopulations.  The first molecular hallmark of immature 
thymocytes entering the Tict/B lineage is V(D)J rearrange- 
ment of the TCR/5 chain locus followed by VJ rearrange- 
ment of the oe chain locus (reviewed in reference 9). Thus, 
V(D)J rearrangement of the TCR B chain locus was ana- 
lyzed in Fc'yRII/III+CD2 -  and FcyRII/III-CD2 +  sub- 
populations of DN  thymocytes derived from day  15.5 of 
gestation. A sensitive PCR-based analysis for TCR gene rear- 
rangement (36) was used as outlined in Fig. 5 A. The PCR 
amplification was carried  out utilizing two sense primers 
hybridizing to two VB genes, VB6 and Vfl8, respectively, 
and one antisense primer recognizing one J~/element, JB2.5. 
Two different V/3-specific primers were used to increase the 
percentage of cells that are included in the analysis for V(D)J 
rearrangement of the TCR B chain. Since the somatic recom- 
bination process leads to joining of a D  to a J element and 
subsequently joining of V to DJ, the DNA sequences that 
are recognized by the V primers (Vp) and the J primers (Jp) 
come into proximity after V(D)J rearrangement and allow 
1084  Early Thymocyte  Development  Marked by FcyRII/IIl and CD2 Expression Figure 5.  TCR B  chain  V(D)J rear- 
rangement in FT day 15.5 DN is es- 
sentially restricted  to  the  Fc'yRIl/ 
III-CD2 +  subset. V(D)J rearrange- 
ment of the TCR B chain locus was 
analyzed in  Fcq,  RII/III+CD2 -  and 
Fc3,RII/III-CD2 + subpopulations of 
DN thymocytes  derived  from day 15.5 
of  gestation. A schematic  representation 
of the PCR-based analysis for B chain 
V(D)J gene rearrangement is depicted 
in A. The DBZJB2 locus is shown in 
gerraline configuration (A,  top). De- 
pending on the rearrangement ofa VB 
gene to either DBZJBZ.1, DBZJ/~2.2, 
D/32JB2.3, D~82JBZ.4, or DBZJB2.5, 
the genomic distance between V and 
DJ elements will differ (A). Five  PCR 
products varying in size from ~850 bp (VB6D~2JB2.1 or VBSDBZJ~2.1) to •150  bp (VB6DB2JB2.5 or VJ58DB2J~2.5) are expected  (A). PCR prod- 
ucts were probed by southern hybridization using an oligonucleotide recognizing the 5' region of the JBZ.5 dement independent flora the J primer 
used for amplification.  B shows the tissue specificity  of TCR B chain V(D)J rearrangement by analyzing genomic DNA derived from adult liver, LN, 
FL day 16.5, FT day 16.5, and FT day 15.5 (B, top, lanes 1-5). In B, bottom, a control PCR reaction shows a 1,058-bp fragment amplified from 
exon 8 of CD3f (B, bottom, lanes I-7). Omission of template DNA in the reaction mixture gave no PCR products (B, lane 8). In C, the relative 
amounts of V(D)J-rearranged genomic DNA is compared between FT15.5 total (/eft), DN Fc'yRII/III +CD2-  (middle), and DN Fc~RII/III-CD2 § 
(right) thymocyte populations. Fivefold  titrations of genomic DNA from 1:1 (corresponding to ,'~100 ng) to 1:625 ('~I60 pg) were analyzed for V(D)J 
rearrangements (C,  top) and in parallel for CD3g" exon 8 as a control (C,  bottom). 
PCR amplification. Depending on the J~2 element to which 
either V~/6 or V~/8 genes are rearranged, five PCR products 
are amplified varying in size from ",~850 bp (VB6D32J32.1 
or V38D32J32.1)  to "2150 bp (V36DB2J32.5 or VB8D32- 
J~2.5) (see Fig. 5 A). To verify the authenticity of the amplified 
sequences, PCR products were probed by southern hybrid- 
ization using  an oligonucleotide recognizing the 5' region 
of the J32.5  element  independent  from  the J  primer  used 
for amplification. 
To test  the  tissue  specificity of this  analysis  for TCR 
chain rearrangement, genomic DNA was prepared from adult 
liver, lymph node (LN), fetal liver from day 16.5 in gestation 
(FL day 16.5), FT day 16.5, and FT day 15.5. As shown in 
Fig.  5 B,  V(D)J rearrangement  within  the/3 gene locus is 
clearly detectable in LN, FT 16.5 day, and, to a lesser extent, 
in FT day 15.5. As expected, no rearrangement is detected 
in DNA derived from adult liver or FL day 16.5. To demon- 
strate the presence of intact DNA  templates in all samples, 
a control PCR reaction was performed that amplified a se- 
quence of 1,058 bp within exon 8 of CD3~" (Fig. 5 B, bottom), 
1085  Rodewald  et al. lanes I-7) from all templates. Both reactions were template 
dependent since omission of template DNA in the reaction 
mixture gave no PCR product (Fig.  5 B,  lane 8). 
In parallel,  V(D)J rearrangement of the B gene locus was 
compared between the two subpopulations of day 15.5 DN 
thymocytes that showed kinetic differences in their in vivo 
development (Fig. 4 B). To this end, FcyRII/III+CD2 -  and 
FcyRII/III-CD2 + subpopulations derived from day 15.5 in 
gestation were separated according to their phenotype by cell 
sorting (see Fig. 4 A), and DNA templates derived from sorted 
subpopulations were tested for B gene V(D)J rearrangement. 
Rearrangement was predominantly detected in the FcyRII/ 
III-CD2 + subpopulation as opposed to Fc3'RII/III+CD2 - 
thymocytes (Fig.  5 B, top, lanes 6  and 7). 
Since this first analysis suggested differences in TCR/3 gene 
V(D)J  rearrangements  between  DN  Fc3,KII/III+CD2 - 
and  DN  Fc"/RII/III-CD2 +  thymocytes,  subsequent  ex- 
periments  were  performed  to  quantify  such  differences. 
Genomic  DNA  templates  from  FT  day  15.5  total,  DN 
Fc~/RII/III+CD2 -, and DN Fc3,RII/III-CD2 + subpopu- 
lations were titrated from 1:1  (corresponding to  -100  ng 
genomic DNA) to 1:625 ("-,160 pg genomic DNA) and used 
as templates to detect V(D)J~ chain rearrangements (Fig.  5 
C, top). Parallel analysis of CD3~" exon 8 was used as a con- 
trol (Fig. 5 C, bottom). Five bands corresponding to V/36  + 
8DB2J~2.1-2.5 are clearly detectable using the highest DNA 
template concentrations in FT day 15.5 total (Fig.  5 C, top 
left) and in DN Fc3,KII/III-CD2 + (Fig. 5 C, top right). The 
amount of amplified DNA derived from the highest tem- 
plate concentration (1:1) from DN Fc3,RII/III+CD2 -  thy- 
mocytes is comparable to the amount of DNA obtained with 
the  1:25 template dilution  from DN  Fc'yRII/III-CD2 + 
thymocytes. Two conditions to allow quantification of tem- 
plate DNA by PCR are fulfilled:  (a) DNA template is not 
present at saturating amounts since the PCR reaction is sen- 
sitive to template titration; and (b) the control amplification 
(Fig.  5 C,  bottom) shows comparable dose-response curves 
for all three tested populations.  If anything, there is more 
template DNA in the FcyRII/III+CD2 -  and FT day 15.5 
total samples relative to the Fc3rRII/III-CD2 + sample based 
on the control CD3~" signal.  Thus, DN Fc3,RII/III-CD2 + 
thymocytes contain  >--25-fold more  V(D)J  (8  chain)-re- 
arranged genomic DNA when compared with DN Fc3,RII/ 
III +  CD2-  thymocytes. Since the sorted populations were 
"~98% pure, it cannot be excluded that the detectable V(D)J 
gene rearrangement among DN Fc'yRII/III +CD2-  thy- 
mocytes is due to contaminating DN  Fc'yRII/III-CD2 + 
cells. Collectively, these data demonstrate that TCR B gene 
V(D)J rearrangement at day 15.5 in gestation is predominantly 
if not  exclusively present  in  the DN  Fc'yKII/III-CD2 + 
subpopulation,  while  the  majority  of the  DN  Fc~/RII/ 
III+CD2 -  thymocytes represent either cells at a pre-V(D)J 
(/$ chain) stage in T cell ontogeny (Fig. 4, B and C) or sepa- 
rate lineages uncommitted to the TCR-c~/B lineage. The latter 
could include cells of the TCR-7/6 lineage or non-T cells. 
However, as shown in Fig. 3, the 3'//~ population represents 
a minor fraction of fetal DN FcyRII/III + thymocytes. Fur- 
thermore, the high level of Thy-1 expression is consistent 
with  a T  lineage designation of the majority of Fc3,RII/ 
III +  CD2-  thymocytes. 
The Majority of  Adult Thymocytes  from Rearrangement-deficient 
RAG-2 -/-  Mice Are  Developmentally Arrested at  the  DN 
CD2- Stage.  Since the expression of Fc3,RII/III marks an 
early pre-VB(D/3)J/3 rearrangement stage in immature thymo- 
cytes and the majority of DN FcyRII/III-CD2 + thymo- 
cytes represent a V(D)J-rearranged stage,  we next analyzed 
adult thymocytes  from recombination-activating gene 2 (KAG- 
2)-deficient mice (19) for expression of FcyRII/III and CD2. 
B and T cells from RAG-2-/-  mice are unable to rearrange 
their  Ig  and  TCR  genes,  respectively,  and  RAG-2 -/- 
thymocytes have previously been shown to be developmen- 
tally arrested at the DN  stage (19).  Normal adult mouse 
thymocytes (see below) as well as thymocytes derived from 
adult  RAG-2 +/-  mice  contain  <3%  of  Fc3,RII/III- 
expressing cells  (Fig.  6 A-C,  top). In contrast,  ~15%  of 
thymocytes derived from RAG-2-/-  mice are Fc3~RII/III + 
(Fig. 6, A-C, bottom), showing that Fc3,RII/III + expression 
is not blocked by the RAG-2 defect. To further analyze this 
thymocyte subset phenotypically, thymocytes derived from 
RAG-2 +/-  mice and  RAG-2 -/-  mice were analyzed by 
two-color immunofluorescence for expression of Fc3,RII/III 
vs. Thy-1, HSA, and CD2, respectively.  To exclude the pos- 
sibility that the hypocellular thymus from RAG-2-/-  mice 
('~100-fold reduction in the total cell number of thymocytes 
[19]) contains relatively enriched populations of contaminating 
Fc'yRII/III + macrophages or granulocytes, thymocytes from 
RAG-2 +/-  mice and tLAG-2 -/-  mice were analyzed for 
coexpression of Thy-1 and HSA vs. Fc3'RII/III.  As shown 
in  Fig.  6,  A  and  B,  while  a  small  fraction  of  the 
Fc3,RII/III +  thymocytes  was  Thy-1-  and  HSA-,  the 
majority coexpressed high levels of Thy-1 (Fig. 6 A, bottom) 
and HSA (Fig. 6 B, bottom), which are phenotypic character- 
istics  of immature thymocytes. 
In view of the fact that the in vivo kinetic experiments 
using fetal thymocytes had indicated a maturation sequence 
of Fc'yRII/III+CD2 -  --* Fc'yRII/III+CD2 + --* Fc'yRII/ 
III-CD2 +,  we  next  analyzed  thymocytes  from  adult 
RAG-2 +/-  mice  and  RAG-2 -/-  mice for  expression  of 
Fc3,RII/III and CD2 (Fig.  6 C).  Interestingly, this pheno- 
typic comparison revealed that the development of DN thymo- 
cytes in  RAG-2 -/-  mice is  blocked before the Fc3,RII/ 
III-CD2 + stage. While RAG-2 +/- mice as well as normal 
adult mice contain ,,o95%  Fc3,RII/III-CD2 §  thymocytes 
and <3% Fc~,RII/III+CD2 + cells (Fig. 6 C, top), <3% of 
RAG-2 -/-  thymocytes are Fc'yRII/III-CD2 + (Fig.  6  C, 
bottom). In contrast to the virtually complete absence of CD4 
and CD8  expression in  RAG-2 -/-  thymocytes, however, 
CD2 expression is not completely abrogated in RAG-2-/- 
mice. Nevertheless, CD2 expression is restricted to <10% 
of  thymocytes  and  is  largely  confined  to  the 
Fc3,RII/III+CD2 + subset. However, the majority (,,o70%) 
of FcyRII/III + thymocytes is CD2-.  It thus appears  that 
two stages  of early thymocyte development (DN Fc3,RII/ 
III+CD2 -  and DN Fc3,RII/III+CD2 +) that were detect- 
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Figure 6.  Phenotypic analysis  of adult thymocytes 
from rearrangement-deficient RAG-2-/- mice reveals 
a  developmental  arrest  at  the  DN  CD2-  stage. 
Thymocytes (A-C) and splenocytes (D) were derived 
from  6-wk-old  homozygous  ILAG-2-/--defieient 
mice (bottom) and from heterozygous control animals 
(RAG-2 +/-) (top). Thymocytes were analyzed for ex- 
pression of Fc'gRlI/III vs. Thy-1 (A), HSA (B), and 
CD2 (C).  Splenocytes were analyzed for expression 
of CD2 vs. B220 (19). RAG-2  +/-  thymocytes con- 
tain <3% of FcTRII/III-expressing  cells (top), while 
•15%  of thymocytes derived from RAG-2-/- mice 
are FcTRII/III  + (bottom).  Note the dramatic reduc- 
tion  in  the  percentage  of  FcyRII/III-CD2  +  in 
RAG-2-/- thymocytes (C, bottom) when compared 
with RAG-2  +/-  thymocytes (C, SOlO  ). 
able in fetal mice are present and, on a percentage basis, over- 
represented in RAG-2-/- mice due to the developmental ar- 
rest.  Thus,  the developmental  progression  of thymocytes 
entering the TCR-oEB pathway as observed in fetal mice 
(Fig. 2 C) appears to be blocked immediately before entry 
into the Fc"/RII/III-CD2 + stage in thymocytes due to the 
RAG-2 mutation, which prevents TCR gene rearrangement. 
However,  ,080%  of the adult RAG-2-/-  thymocytes ex- 
press neither CD2 nor FcyRII/[II and thus cannot be as- 
signed to the developmental sequence described herein. Note 
that in view of the hypocellularity of the RAG-2-/- thymus 
(19), the absolute number of FcTRII/III + thymocytes is not 
increased, suggesting that the rearrangement defect perturbs 
early development,  which directly or indirectly affects the 
generation of FcTRII/III + and CD2 + thymocytes. 
In contrast to mature human B lymphocytes, murine B cells 
express CD2 (47, 48). The finding that the expression of CD2 
in thymocytes is largely abrogated in RAG-2-/- mice (Fig. 
6 C) prompted us to analyze the potential  influence of the 
developmental blockade at the pro-B cell stage (Ig genes in 
germline, B22ff  ~  on the expression of CD2 in RAG-2-/- 
mice. Splenocytes derived from RAG-2 +/-  (Fig. 6 D, top) 
and RAG-2-/-  (Fig. 6 D,  bottom) mice were analyzed for 
expression of CD2 vs. B220. While the majority of B lin- 
eage cells in the RAG-2 §  spleen express high levels of 
B220,  B lineage  cells from RAG-2-/-  mice express low 
levels of B220 (Fig. 6 D, bottom), as described (19, 49). All 
B220hig h splenocytes from RAG-2 +/- spleen coexpress CD2. 
In  contrast,  RAG-2-/-  splenocytes  contain  both 
B220+CD2 + and B220+CD2 -  cells, suggesting that CD2 
can be expressed in B cell progenitors that carry their Ig genes 
still in germline configuration.  Thus, in contrast to T cell 
progenitors,  the RAG-2 mutation does not appear to block 
CD2 expression in the B lineage. 
Normal  Adult  CD3- CD4- CDS-  Thymocytes  Contain 
FcTRII/III+CD2 -,  Fc'yRII/III+CD2 +  and  FcTRII/III- 
CD2 + Subpopulations.  To test whether Fc"/RII/III+CD2 -, 
FcyRII/III +  CD2 +, or FcyRII/III- CD2 + thymocyte sub- 
populations  are also present in postnatal life among imma- 
ture thymocytes, CD3- CD4-CDS-  thymocytes were purl- 
fled from the adult thymus. To this end, adult thymocytes 
were stained with a combination of anti-CD3, anti-CD4, 
and anti-CD8 mAbs, and antibody-coated cells were subse- 
quently removed by two rounds of magnetic bead depletion 
followed by cell sorter separation. This purification method 
yielded "098% pure CD3- CD4-CD8-  thymocytes. CD3- 
CD4-CD8-  thymocytes were then examined for expression 
of FcyRII/III and CD2 (Fig. 7 D). Negative controls as well 
as single-color controls are shown in Fig. 7, A-C. To test 
specific  binding of mAb 2.4G2 to the thymocytes, the binding 
of 2.4G2-FITC  was blocked by preincubation  with excess 
of unlabeled  2.4G2  (Fig.  7  A).  "015% of CD3-CD4- 
CDS- thymocytes express FcTRII/III (Fig. 7 B), and ,020% 
stain weakly for CD2 (Fig. 7 C). Two-color FcTRII/III and 
CD2 fluorescence  analysis reveals "012% Fc~RII/III +  CD2-, 
"04%  FcTRII/III+CD2 +, and "016% FcTRII/III-CD2 + 
thymocytes (Fig. 7 D). These subpopulations  of Fc~RII/ 
III+CD2 -  and  FcTRII/III-CD2 +  among  normal  adult 
CD3-CD4-CDS-  thymocytes resemble  the  phenotypic 
subpopulations identified in fetal development (Fig. 2 C), as 
well as after the developmental arrest in RAG-2-deficient mice 
(Fig. 7 C). In contrast to RAG-2-/- thymocytes, however, 
normal adult CD3-  CD4-CDS-  thymocytes do contain a 
substantial percentage of FcTRII/III- CD2 + cells (>15%). 
A  B  C  D 
0.3  I  0.1  _0.2  I  0.1  20.1 /  0.3  16.4  3.6 
99.0  Control  65.0 FcyRII/III  79.4  Control  67.9 FcyRIl/lI! 
Figure 7.  Phenotypic analysis  of adult CD3-CD4-CD8- thymocytes 
identifies  FcTKII/III+CD2  -,  FcTIUI/III*CD2  +,  and  FcTRII/III  + 
CD2 + subpopulations in postnatal life, Adult CD3-CD4-CD8- thymo- 
cytes are prepared as described in Materials and Methods, Cells were stained 
with avidin-PE vs. 2.4G2-FITC after preincubation with excess of unla- 
beled 2.4G2 (A), for avidin-PE  vs. 2.4G2-FITC (B), for CD2-biotin followed 
by avidin-PE vs. 2.4G2-FITC after preincubation  with excess of unlabded 
2.4G2 (C) and with CD2-biotin  foUowed  by avidin-PE  vs. 2AG2-FITC (D). 
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In previous work, we have identified the expression of Fc3' 
receptors for IgG (Fc~RII/III, CD16) on the majority of early 
fetal (DN) thymocytes (13). In addition to the early appear- 
ance of this cell population in thymic ontogeny, several ob- 
servations suggested that the Fc'yRII/III + thymocyte popu- 
lation would represent an early stage in T cell development. 
First, this cell population contains relatively uncommitted 
cells, which could give rise  to T  cells and NK cells in a 
microenvironment-dependent way. Second, Fc3,RII/III ex- 
pression was shown to be downregulated early in thymocyte 
development (between the DN and DP stages).  Although 
Fc~RII/III expression precedes the cell surface expression of 
TCR-c~/B by several days in gestation, Fc3,RII/III down- 
regulation appears to correlate with the entry of developing 
thymocytes into the TCR Tiol/B lineage pathway. Support 
for this view comes from the finding that loss of Fc3~RII/III 
expression is only induced in the thymus. In contrast, early 
fetal thymocytes grown in in vitro suspension cultures in the 
presence of IL-2, or "parked" in the spleen in vivo after intra- 
venous transfer of donor-type fetal thymocytes, maintained 
expression  of Fc3~RII/III  (13). 
Here we provide further evidence that FcyRII/III expres- 
sion is detectable at very early stages of intrathymic develop- 
ment and, more precisely, characterized  its appearance and 
disappearance. We observe that on day 15.5 of gestation, the 
majority  of  the  ontogenetically primitive population of 
CD4  l~  SP thymocytes is Fc3~RII/III + (Fig.  1 D).  More- 
over, fractions of FcyRII/III + thymocytes include Thy-1 l~ 
IL-2R (p55)-, CD2-, and HSA  l~  cells (Fig. 2, A-D). Very 
early intrathymic progenitor populations have been pheno- 
typically characterized as Thy-1 l~  Scal +, HSA  l~  Pgp-1 +, 
CD3-,  CD4 -/~ow, CD8-,  IL-2R  (p55)-  (38,  42, 43, 45, 
50).  Consequently, the phenotype of at least a fraction of 
the Fc3~RII/III-expressing thymocytes is consistent with the 
expression  pattern  of  very  early  thymocytes.  However, 
Fc3,RII/III-expressing thymocytes also include more mature 
DN  stages of thymocyte development. 
In  preliminary  experiments  designed  to  test  whether 
prethymic hematopoietic cells derived from fetal liver con- 
tain FcyRII/III + T  cell progenitors, we isolated  Fc3,RII/ 
III + fetal liver cells from day 15.5 in gestation (representing 
5-15 % of the total population), and analyzed their develop- 
mental potential upon intrathymic injection in vivo. FcyRII/ 
III § fetal liver cells contained T cell progenitor activity, but 
did not appear to provide a means to enrich for such activity 
since Fc3'RII/III- fetal liver cells also expressed T cell pro- 
genitor activity (not shown). Collectively, these experiments 
indicate that developing thymocytes express Fc3'RII/III very 
early in T  cell ontogeny and that fetal liver-derived T  cell 
progenitors potentially carry FcyRII/III as thymic immigrants. 
The progenitor activity of DN Fc3,RII/III § cells for the 
generation of TCR-ol/B + thymocytes inside the thymus has 
been demonstrated (13). In the present work, the kinetics 
of this in vivo differentiation is described in detail. It is also 
likely that a fraction of DN Fc-yRII/III- thymocytes enters 
the TCR-3~/8 lineage. While we have previously identified 
Fc3d~II/III + TCR-3~/8 + thymocytes after in vitro culture 
of fetal thymocytes in the presence of IL-2 (13), the current 
study demonstrates the presence of such cells in situ. Although 
the  precursor-product  relationship  of  DN  Fc'yRII/III + 
thymocytes and mature TCR-3,/8 + T  cells remains to be 
directly shown, it is conceivable that the Fc'),RII/III + TCR- 
"y/8 + thymocytes identified herein represent an intrathymic 
stage of TCR-y/~ epidermal dendritic T cells. It is noteworthy 
that these epidermal cells express Fc~RII/III (51). 
Developing thymocytes entering the TCR-ol/3 pathway 
cease to express FcyRII/III at the DN stage and before the 
entry into the CD3-CD8 l~  stage. Later phases of thymo- 
cytes (DP and mature SP) are Fc3~RII/III- (Fig. 1 B). This 
downregulation of Fc3,RII/III expression  at an immature 
thymocyte stage is in contrast to FcyRII expression during 
B cell ontogeny. Recently, phenotypic analysis of developing 
B cells has demonstrated the expression of Fc3~RII as early 
as at the pre-B cell stage (52). Unlike mature T cells, how- 
ever, B lineage cells continue to express Fc~ receptors as ma- 
ture B cells (53,  54). 
Interestingly, the downregulation of FcyRII/III expres- 
sion on DN thymocytes entering the TCR-od3 pathway con- 
trasts with the upregulation of CD2just before the exit from 
the DN stage and allows the separation  of DN thymocytes 
into three novel phenotypic subsets. The sequential appear- 
ance in  thymic ontogeny of first  Fc3,RII/III+CD2 -  and 
latter Fc~RII/III-CD2 + thymocytes (Fig. 2 C) was assessed 
by flow cytometry. Moreover, the developmental delay of CD4 
and CD8 coexpression  as well as the generation of mature 
SP thymocytes (Fig. 4 B) by ~48 h after intrathymic injec- 
tion of FcyRII/III+CD2 -  when compared with Fc~RII/ 
III-CD2 §  characterize  Fc3,RII/III+CD2 -  and  Fc~RII/ 
III-CD2 +  DN  subsets  as  distinct  early  and late  stages, 
respectively,  of the same pathway leading into the Tio~/3 
lineage. 
Our kinetic measurements of the development of fetal 
thymocytes entering the TCR-oc/B pathway after adoptive 
transfer  into normal nonirradiated recipients  are consistent 
with previously reported in vivo kinetics of developing thymo- 
cytes. The transition time from the DN to the DP stage, 
ranging from 1.5 d (FcyRII/III+CD2 -) to 3.5 d (Fc?RII/ 
III-CD2 +)  (Fig.  4 B),  resembles  the in vivo kinetics re- 
ported by Petriet al. (34), who compared maturational stages 
of adult DN Pgp-1-  IL-2Rot + and DN Pgp-1-  Ib2Ro~- 
thymocytes in normal recipient mice. Progeny of Fc3,RII/ 
III +  CD2-  and Fc3'RII/III- CD2 + DN thymocytes remain 
at the DP stage for 48-72 h (Fig. 4 B) before they are selected 
into the SP thymocyte compartment (Fig. 4 C). Huesmann 
et al. (55) estimated the life span of DP thymocytes in TCR 
transgenic mice using bromodeoxyuridine (BrdU) labeling 
in vivo to be 3.5 d. Thus, both in vivo DNA labeling and 
adoptive transfer of precursor populations into normal, nonir- 
radiated recipients yield comparable kinetics and are most likely 
to reflect the steady-state physiology of intrathymic T  cell 
development. 
Undifferentiated "prothymocytes" entering the thymus 
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Subsequently, these precursors may evolve along TCR-y/& 
TCR-cff~, or non-T lineages. The order of somatic recombi- 
nation events acting on the different TCR gene loci in thymo- 
cytes at the early stages of thymocyte differentiation is de- 
velopmentally regulated (7, 8). The somatic recombination 
process in Tic~//5 T cell progenitors leading to antigen receptor 
diversity in mature lymphocytes begins by rearrangement of 
first the TCR/5 locus (/5 chain V[DlJjoining first detectable 
at day 15 in gestation) and subsequently the TCR c~ locus. 
Transcripts encoding both TCR chains are expressed by day 
17 in gestation (reviewed in reference 9). Our analysis of the 
V(D)J/5 gene rearrangement status in DN subpopulations 
at  day  15.5  in  gestation has  identified DN  Fcq,  RII/III + 
CD2-  cells as being primarily at a pre-V(D)J stage, whereas 
V(D)J  ~  chain rearrangement  is  readily  apparent  in  the 
FcyRII/III-CD2 +  subset.  Although some DN  FcyRII/ 
III +  CD2-  cells may be committed to the TCR-y/~ rather 
than TCR-od/5 lineage, this fraction is small (Fig. 3). Like- 
wise, the pool of nonoT lineage cells contained within the 
DN FcyRII/III+CD2-  subpopulation appears small given 
the high Thy-1 and HSA expression on this population (Fig. 
2). The difference in rearrangement status directly supports 
our  suggestion  that  DN  Fcq,  RII/III+CD2 -  and  DN 
Fc3,RII/III-CD2 + cells are early and late DN populations, 
respectively.  Furthermore, V(D)J/5 chain rearrangement is 
temporally correlated with the termination of FcyRII/III ex- 
pression. 
The molecular understanding of antigen receptor gene rear- 
rangement has been advanced by the identification of two 
recombination activation genes, termed RAG-1 and tLAG-2 
(reviewed  in  references  56  and  57).  RAG-1  and  RAG-2 
mRNAs are expressed in immature B and T lymphocyte pro- 
genitor populations that  actively  rearrange  their  antigen 
receptor genes. Together, these genes confer recombination 
activity upon transfection into nonrearranging cells (18). Until 
recently, little was known about the influence of productive 
TCR gene rearrangements on the regulation of intrathymic 
developmental progression. Gene-targeting experiments in 
which RAG-1 or RAG-2 loci were mutated have now demon- 
strated the essential nature of both genes for the somatic recom- 
bination process  (19, 49).  Mice expressing the RAG-1 -/- 
or RAG-2  -/- genotype lack both mature B and T lympho- 
cytes and thus, in phenotype, resemble animals with a natu- 
rally occurring SCID syndrome (reviewed in reference 58). 
Specifically, thymocytes from RAG-2-/-  mice are develop- 
mentally arrested at the DN stage before the assembly and 
surface expression of the TCR. In addition, the RAG-2 mu- 
tation leads to a reduction to '~1% of the normal number 
of thymocytes (19). Similar effects have been noted in SCID 
mice since SCID  thymocytes are also arrested  at  the DN 
stage  (58). 
While both DN  Fcq'RII/III+CD2 -  and DN  FcyRII/ 
III+CD2 §  populations are present and their relative  per- 
centages  enriched  in  RAG-2 -/-  when  compared  with 
RAG-2 +/-  thymocytes, strikingly,  the DN  Fc~RII/III- 
CD2 + population is reduced from >95%  (RAG-2 +/-) to 
<3%  (RAG-2 -/-)  (Fig.  6 C).  Thus, persistence  of TCR 
genes in germline configuration in the early developing thymo- 
cytes has a dramatic inhibitory effect, directly or indirectly, 
on CD2 expression at the late DN stage. Expression of CD2 
occurs after V(D)J/5 chain rearrangement in thymic devel- 
opment and, much like CD4 and CD8 expression (19, 49), 
appears to be,  in large part, linked to V(D)J/5 chain rear- 
rangement. In this context, it is interesting that transfection 
of a TCR/3 chain gene into a SCID-derived cell line led to 
upregulation of CD2 surface expression in addition to sur- 
face expression of a Ti/5-/5 homodimer (59).  The mecha- 
nism by which the rearranged TCR/5 chain mediates tran- 
scriptional and/or translational control of these genes and 
their products remains to be determined. These results sug- 
gest that the expression of the TCR ~ chain provides a crit- 
ical signal for development beyond the DN and into the DP 
stage. Consistent with this hypothesis, SCID mice expressing 
a transgenic TCR/5 chain contain normal percentages of DP 
thymocytes (59). Moreover,  in RAG-l-/-  and RAG-2-/- 
mice, which carry fully rearranged transgenic TCR/3 chains, 
thymocytes are released from their differentiation block at 
the DN stage and progress into the DP stage (60,  61). 
The role of Fc3'RII/III on early CD4  ]~  thymocytes and 
DN thymocytes during thymic differentiation is unknown. 
However, signaling function through the associated FceRI'y 
(62) or CD3~" (63-65) subunits may be important in the de- 
velopmental process, mRNAs encoding FceRI3' and CD3~" 
proteins are present in the developing thymus as early as day 
14 of gestation (13; data not shown). While IgG is the ligand 
of FcyRII/III on mature hematopoietic elements and NK 
cells, it is possible  that an alternative ligand interacts with 
the ectodomain of Fcq,  RII/III expressed  on early  thymic 
precursors. It is now important to define the precise function 
of this molecule during thymocyte development. 
It is apparent that there is no requirement for CD2 ex- 
pression before induction of TCR gene rearrangement. This 
notion is consistent with the previous demonstration of the 
presence of CD2-CD3 + DN thymocytes in the mouse (14). 
Rather, TCR/5 gene V(D)J rearrangement in DN thymo- 
cytes is necessary for normal CD2 surface expression.  More 
specifically, fixation of the TCR genes in germline configu- 
ration largely prevents the differentiation of DN  thymo- 
cytes into the Fc'yRII/III-CD2 + stage.  It is undoubtedly 
noteworthy that CD2 expression precedes and is maintained 
through the DP thymocyte stage because it is at this latter 
stage that positive and negative selection events are ongoing. 
The adhesion function of CD2 may well facilitate cell-cell 
contact important in the thymic "education" process. In this 
regard, repertoire selection of the TCRs in humans and mice 
could be influenced by the presence of CD2. Clearly, further 
studies are required to address this issue, particularly because 
murine and human CD2 bind related but distinct ligands, 
CD48 and CD58 (LFA-3), respectively, with different tissue 
distributions  (66).  Nonetheless,  the  functional dissection 
provided by the elucidation of the DN subpopulations de- 
scribed through our analysis should allow us to further define 
the orderly steps in thymic development in the mouse. 
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